Assessment of HIV molecular surveillance capacity in the European Union, 2016.

about

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

Item

http://www.wikidata.org/entity/Q47106233

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@en

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@nl

type

Item

label

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@en

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@nl

prefLabel

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@en

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@nl

P1476

Assessment of HIV molecular surveillance capacity in the European Union, 2016.

@en

P2093

Anastasia Pharris

http://www.w3.org/2001/XMLSchema#string

Andrew J Amato-Gauci

http://www.w3.org/2001/XMLSchema#string

Annemarie Wensing

http://www.w3.org/2001/XMLSchema#string

Eeva Broberg

http://www.w3.org/2001/XMLSchema#string

Katrin Leitmeyer

http://www.w3.org/2001/XMLSchema#string

Patrick Keating

http://www.w3.org/2001/XMLSchema#string

Stefania De Angelis

http://www.w3.org/2001/XMLSchema#string

P2860

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

Dispersion of the HIV-1 Epidemic in Men Who Have Sex with Men in the Netherlands: A Combined Mathematical Model and Phylogenetic Analysis

HIV-1 drug resistance and resistance testing.

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance.

A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa.

P31

scholarly article

P356

10.2807/1560-7917.ES.2017.22.49.17-00269

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29233253

http://www.w3.org/2001/XMLSchema#string

P932

5727594

http://www.w3.org/2001/XMLSchema#string